Reviv3 Procare CO (RVIV) financial statements (2021 and earlier)

Company profile

Business Address 9480 TELSTAR, SUITE 5
EL MONTE, CA 91731
State of Incorp. DE
Fiscal Year End May 31
SIC 2844 - Perfumes, Cosmetics, and Other Toilet Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2020
Q2
8/31/2020
Q1
5/31/2020
Q4
2/29/2020
Q3
11/30/2019
Q2
8/31/2019
Q1
5/31/2019
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments579423 143345338346
Cash and cash equivalents579423 143345338346
Inventory, net of allowances, customer advances and progress billings323506 344302310265
Inventory323506 344302310265
Other undisclosed current assets9379 61534883
Total current assets:9951,008 548699695693
Noncurrent Assets
Other noncurrent assets224243 269535448
Total noncurrent assets:224243 269535448
TOTAL ASSETS:1,2201,251 818752749741
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:326333 641678732
Accounts payable276299 481526815
Other undisclosed accounts payable and accrued liabilities5034 16151918
Debt8782 69   
Due to related parties2912 0880
Other undisclosed current liabilities2196 20216720
Total current liabilities:463524 15219616252
Noncurrent Liabilities
Long-term debt and lease obligation245268 151   
Long-term debt, excluding current maturities153156     
Finance lease, liability93112 151   
Other undisclosed noncurrent liabilities78 10101112
Total noncurrent liabilities:252275 161101112
Total liabilities:715799 31320617364
Stockholders' equity
Stockholders' equity attributable to parent504451 505546577677
Common stock44 4444
Additional paid in capital5,3275,327 5,3115,3115,3115,311
Accumulated deficit(4,827)(4,880) (4,811)(4,769)(4,739)(4,638)
Total stockholders' equity:504451 505546577677
TOTAL LIABILITIES AND EQUITY:1,2201,251 818752749741

Income statement (P&L) ($ in thousands)

11/30/2020
Q2
8/31/2020
Q1
5/31/2020
Q4
2/29/2020
Q3
11/30/2019
Q2
8/31/2019
Q1
5/31/2019
Q4
Revenues644268 158329126330
Cost of revenue
(Cost of Goods and Services Sold)
(248)(136) (46)(170)(45)(171)
Gross profit:396132 11215981159
Operating expenses(342)(200) (153)(189)(183)(155)
Operating income (loss):55(68) (41)(30)(103)5
Nonoperating income (expense)(1)(1) (0)(0)2(0)
Interest and debt expense(1)(1) (1)(1)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:52(71) (42)(31)(101)5
Other undisclosed income from continuing operations before income taxes11 1100
Net income (loss) available to common stockholders, diluted:53(69) (42)(30)(101)5

Comprehensive Income ($ in thousands)

11/30/2020
Q2
8/31/2020
Q1
5/31/2020
Q4
2/29/2020
Q3
11/30/2019
Q2
8/31/2019
Q1
5/31/2019
Q4
Net income (loss):53(69) (42)(30)(101)5
Comprehensive income (loss), net of tax, attributable to parent:53(69) (42)(30)(101)5

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: